Used to prevent chromium deficiency and to decrease serum glucose and insulin levels. It also decreases plasma lipid levels and platelet aggregation and improves myocardial contractility. (C003B-255417)

Chromium picolinate is clinically used to decrease fasting blood glucose and insulin levels. Chromium picolinate exhibits anti-hyperlipidemic, cardioprotective, and anti-diabetic activities. In high-fat diet-fed rats, chromium picolinate decreases plasma lipid levels and platelet aggregation. In spontaneously hypertensive rats, this compound improves myocardial contractility, myocardial relaxation, and coronary blood flow after cardiac ischemia/reperfusion.

UPC:

51322500

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

C2965-25 g

CAS:

14639-25-9